These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

547 related items for PubMed ID: 20587123

  • 61. Status report on the Childhood Immunization Initiative: reported cases of selected vaccine-preventable diseases--United States, 1996.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1997 Jul 25; 46(29):665-71. PubMed ID: 9237476
    [Abstract] [Full Text] [Related]

  • 62. Rubella seroprevalence in the first birth cohort reaching fertility age after 20 years of two dose universal vaccination policy in Israel.
    Levine H, Ankol OE, Rozhavski V, Davidovitch N, Aboudy Y, Zarka S, Balicer RD.
    Vaccine; 2012 Nov 26; 30(50):7260-4. PubMed ID: 23063839
    [Abstract] [Full Text] [Related]

  • 63. Serosurveillance of vaccine preventable diseases and hepatitis C in healthcare workers from Lao PDR.
    Black AP, Vilivong K, Nouanthong P, Souvannaso C, Hübschen JM, Muller CP.
    PLoS One; 2015 Nov 26; 10(4):e0123647. PubMed ID: 25874696
    [Abstract] [Full Text] [Related]

  • 64. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
    Zhou F, Reef S, Massoudi M, Papania MJ, Yusuf HR, Bardenheier B, Zimmerman L, McCauley MM.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S131-45. PubMed ID: 15106102
    [Abstract] [Full Text] [Related]

  • 65. From the Centers for Disease Control and Prevention. Update: childhood vaccine-preventable diseases--United States, 1994.
    JAMA; 1994 Nov 02; 272(17):1318-9. PubMed ID: 7933383
    [No Abstract] [Full Text] [Related]

  • 66. Resurgence risk for measles, mumps and rubella in France in 2018 and 2020.
    Béraud G, Abrams S, Beutels P, Dervaux B, Hens N.
    Euro Surveill; 2018 Jun 02; 23(25):. PubMed ID: 29945697
    [Abstract] [Full Text] [Related]

  • 67. Progress toward measles and rubella elimination in Egypt.
    El Sayed N, Kandeel N, Barakat I, Moussa I, Alexander JP, Naouri B, Reef SE.
    J Infect Dis; 2011 Jul 02; 204 Suppl 1():S318-24. PubMed ID: 21666180
    [Abstract] [Full Text] [Related]

  • 68. Seroprevalence of Measles, Rubella, Tetanus, and Diphtheria Antibodies among Children in Haiti, 2017.
    Minta AA, Andre-Alboth J, Childs L, Nace D, Rey-Benito G, Boncy J, Adrien P, Francois J, Phaïmyr Jn Charles N, Blot V, Vanden Eng J, Priest JW, Rogier E, Tohme RA.
    Am J Trop Med Hyg; 2020 Oct 02; 103(4):1717-1725. PubMed ID: 32618256
    [Abstract] [Full Text] [Related]

  • 69. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W, Bucholc B, Wysokińska T, Górska P, Gniadek G.
    Przegl Epidemiol; 2003 Oct 02; 57(2):281-8. PubMed ID: 12910596
    [Abstract] [Full Text] [Related]

  • 70. Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey.
    Amela C, Pachón I, de Ory F.
    Eur J Epidemiol; 2003 Oct 02; 18(1):71-9. PubMed ID: 12705626
    [Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. Antibodies to measles, mumps, and rubella virus in Thai children after two-dose vaccination at 9 months and 2.5 years: A longitudinal study.
    Wanlapakorn N, Puenpa J, Thongmee T, Srimuan D, Thatsanathorn T, Vongpunsawad S, Poovorawan Y.
    Vaccine; 2020 May 19; 38(24):4016-4023. PubMed ID: 32331806
    [Abstract] [Full Text] [Related]

  • 73. [Post-transplantation vaccination of bone-marrow transplant recipients].
    Adell C, Bayas JM, Vilella A, Perales M, Vidal J, Bertran MJ, Rojano X, Asenjo MA.
    Med Clin (Barc); 2002 Oct 05; 119(11):405-9. PubMed ID: 12381273
    [Abstract] [Full Text] [Related]

  • 74. [Seroprevalence of measles, rubella, mumps and varicella in health workers in the Community of Madrid].
    Rodríguez ML, Martínez D, Santos-Sancho JM, Borda JR, Orero A.
    Rev Esp Quimioter; 2014 Jun 05; 27(2):98-101. PubMed ID: 24940889
    [Abstract] [Full Text] [Related]

  • 75. Seroprevalence of measles, mumps and rubella among children in American Samoa, 2011, and progress towards West Pacific Region goals of elimination.
    Mahamud A, Masunu-Faleafaga Y, Walls L, Williams N, Garcia P, Teshale E, Williams R, Dulski T, Bellini WJ, Kutty PK.
    Vaccine; 2013 Aug 12; 31(36):3683-7. PubMed ID: 23770334
    [Abstract] [Full Text] [Related]

  • 76. Low immunity against vaccine preventable diseases in Turkish HIV cohort.
    Candevir A, Kuşcu F, Yıldırım F, Kömür S, Şentürk GÇ, İnal AS, Eser F, Çetiner S, Kurtaran B, Taşova Y.
    Turk J Med Sci; 2021 Oct 21; 51(5):2311-2317. PubMed ID: 33984893
    [Abstract] [Full Text] [Related]

  • 77. Seroprevalence of Maternal and Cord Antibodies Specific for Diphtheria, Tetanus, Pertussis, Measles, Mumps and Rubella in Shunyi, Beijing.
    Meng QH, Liu Y, Yu JQ, Li LJ, Shi W, Shen YJ, Li L, Zhan SN, Yang F, Wang YJ, Yao KH.
    Sci Rep; 2018 Aug 29; 8(1):13021. PubMed ID: 30158679
    [Abstract] [Full Text] [Related]

  • 78. Adult immunizations: update on recommendations.
    Pham H, Geraci SA, Burton MJ, CDC Advisory Committee on Immunization Practices.
    Am J Med; 2011 Aug 29; 124(8):698-701. PubMed ID: 21658665
    [Abstract] [Full Text] [Related]

  • 79. From the Centers for Disease Control and Prevention. Reported vaccine-preventable diseases--United States, 1993, and the childhood immunization initiative.
    JAMA; 1994 Mar 02; 271(9):651-2. PubMed ID: 8309018
    [No Abstract] [Full Text] [Related]

  • 80. [The triple virus vaccine: old viruses, new problems].
    de Ory F, Sanz JC, García Bermejo IM.
    Enferm Infecc Microbiol Clin; 2007 Apr 02; 25(4):227-9. PubMed ID: 17386215
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.